.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Deloitte
Argus Health
Fish and Richardson
Express Scripts
Chubb
Colorcon
Healthtrust
Covington
Cerilliant

Generated: September 23, 2017

DrugPatentWatch Database Preview

VERSAPEN Drug Profile

« Back to Dashboard

What is the patent landscape for Versapen, and when can generic versions of Versapen launch?

Versapen is a drug marketed by Bristol and is included in three NDAs.

The generic ingredient in VERSAPEN is hetacillin potassium. There are six drug master file entries for this compound. Additional details are available on the hetacillin potassium profile page.

Summary for Tradename: VERSAPEN

Patents:0
Applicants:1
NDAs:3
Bulk Api Vendors: see list14
Patent Applications: see list1,467
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VERSAPEN at DailyMed
Applicant Tradename Generic Name Dosage NDA >Approval Date TE Type RLD RS Patent No. >Patent Expiration Product Substance Delist Req. >Exclusivity Expiration
Bristol
VERSAPEN
hetacillin
FOR SUSPENSION;ORAL050060-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol
VERSAPEN
hetacillin
FOR SUSPENSION;ORAL061398-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol
VERSAPEN
hetacillin
FOR SUSPENSION;ORAL050060-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol
VERSAPEN
hetacillin
FOR SUSPENSION;ORAL061398-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol
VERSAPEN-K
hetacillin potassium
CAPSULE;ORAL061396-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Bristol
VERSAPEN-K
hetacillin potassium
CAPSULE;ORAL061396-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Mallinckrodt
Boehringer Ingelheim
Cerilliant
US Army
Merck
Express Scripts
Fuji
Colorcon
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot